[April 23, 2014] |
|
Research and Markets: Global Seasonal Influenza Therapeutics Pipeline Review 2014 - Analysis of 29 Companies & 44 Companies
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/j8v679/seasonal)
has announced the addition of the "Seasonal
Influenza - Pipeline Review, H1 2014" report to their offering.
This report provides comprehensive information on the therapeutic
development for Seasonal Influenza, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Seasonal
Influenza and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Scope
-
The report provides a napshot of the global therapeutic landscape of
Seasonal Influenza
-
The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
-
The report reviews key players involved in the therapeutics
development for Seasonal Influenza and enlists all their major and
minor projects
-
The report summarizes all the dormant and discontinued pipeline
projects
-
A review of the Seasonal Influenza products under development by
companies and universities/research institutes based on information
derived from company and industry-specific sources
-
Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
-
A detailed assessment of monotherapy and combination therapy pipeline
projects
-
Coverage of the Seasonal Influenza pipeline on the basis of target,
MoA, route of administration and molecule type
-
Latest news and deals relating related to pipeline products
Companies Involved in Therapeutics Development
-
GlaxoSmithKline plc
-
Lentigen Corporation
-
Celltrion, Inc.
-
Liquidia Technologies, Inc.
-
Novartis AG
-
Novavax, Inc.
-
Crucell N.V.
-
BioDiem Ltd
-
Eurocine Vaccines AB
-
Colby Pharmaceutical Company
-
Bionor Pharma ASA
-
FluGen, Inc.
-
TechnoVax, Inc.
-
Theraclone Sciences, Inc.
-
NanoBio Corporation
-
Protein Sciences Corporation
-
Vaxart, Inc.
-
VBI Vaccines
-
AIMM Therapeutics B.V.
-
Cilian AG
-
AmVac AG
-
TSRL, Inc.
-
Vaxine Pty Ltd
-
AltraVax Inc.
-
Big DNA Ltd.
-
PeptiVir, Inc.
-
Inhibikase Therapeutics, Inc.
-
Codagenix, Inc.
-
Lakewood-Amedex Inc.
For more information visit http://www.researchandmarkets.com/research/j8v679/seasonal
[ Back To TMCnet.com's Homepage ]
|